均瑶健康：公司2025年度业绩受多重因素影响出现亏损，公司高度重视经营改善

Core Viewpoint - Junyao Health is expected to incur losses in the fiscal year 2025 due to multiple influencing factors, and the company is focusing on operational improvements and strategic transformation to enhance performance and return value to investors [2] Group 1: Financial Performance - The company anticipates a loss in its 2025 fiscal year, influenced by various factors [2] - Junyao Health is committed to improving its operational efficiency and cost management to mitigate losses [2] Group 2: Strategic Initiatives - The company is concentrating on the core technology development of probiotics and integrating its supply chain [2] - Junyao Health is actively pursuing market expansion through channel optimization and new product development [2]